Skip to content

Back to all articles

FDA Clears Optellum’s Clinical Decision Support Software to Diagnose Lung Cancer

23 March 2021

FDA Clears Optellum’s Clinical Decision Support Software to Diagnose Lung Cancer

In this post

RT Magazine (Respiratory Care Magazine) has published a story about Optellum's FDA clearance.

Read the full article here.

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

23 December 2022 / Events

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

150 most promising digital health companies of 2022, according to CB Insights

07 December 2022 / US

150 most promising digital health companies of 2022, according to CB Insights

150 most promising digital health companies of 2022, according to CB Insights

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

26 November 2021 / Partnerships

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence